A Phase III Trial to Evaluate the Efficacy and Safety of Biweekly Alirocumab in Patients on a Stable Dialysis Regimen: The Alidial Study
Phase of Trial: Phase III
Latest Information Update: 24 Oct 2018
At a glance
- Drugs Alirocumab (Primary)
- Indications Hypercholesterolaemia
- Focus Therapeutic Use
- Acronyms Alidial Study
- 15 Oct 2018 Status changed from not yet recruiting to recruiting.
- 31 Aug 2018 Biomarkers information updated
- 05 Apr 2018 Planned initiation date changed from 1 Apr 2018 to 1 May 2018.